Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase. This is part of Atlas Special
Leuven, BELGIUM, Boston, MA, US – June 1, 2023 – 8.00 AM CET – Oxurion NV , a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with... | June 1, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US – June 1, 2023 – 7.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic... | June 1, 2023
Regulated Information Leuven, BELGIUM, Boston, MA, US - June 1, 2023 - 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic
Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 22 convertible bonds in Oxurion resulting in a EUR 550,000 capital increase. This is part of Atlas